Clinical trials
Recruiting Squamous Cell Carcinoma of Head and Neck trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 3 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bicara Therapeutics | 1 |
| Exelixis | 1 |
| GlaxoSmithKline | 1 |
| John O. Prior | 1 |
| Medicenna Therapeutics, Inc. | 1 |
| Olgun Elicin | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
| University Hospital Freiburg | 1 |
| Universität des Saarlandes | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 9 |
| Head and Neck Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Renal Cell | 2 |
| Colorectal Neoplasms | 2 |
| Esophageal Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Stomach Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
| Uterine Cervical Neoplasms | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.